Biogen Inc. (BIIB) CEO Michel Vounatsos on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
Biogen Inc. (BIIB)
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
biogen.com/en_us/investors.html
Company Research
Source: Seeking Alpha
Biogen Inc. (NASDAQ: BIIB ) Q3 2018 Results Earnings Conference Call October 23, 2018 8:00 AM ET Executives Matt Calistri - Vice President, Investor Relations Michel Vounatsos - Chief Executive Officer Michael Ehlers - EVP, Research & Development Jeff Capello - Chief Financial Officer Al Sandrock - Chief Medical Officer Analysts Umer Raffat - Evercore Geoff Meacham - Barclays Geoffrey Porges - Leerink Matthew Harrison - Morgan Stanley Ying Huang - Bank of America Merrill Lynch Cory Kasimov - JPMorgan Michael Yee - Jefferies Phil Nadeau - Cowen and Company Carter Gould - UBS Salim Syed - Mizuho Robyn Karnauskas - Citi Ronny Gal - Bernstein Terence Finn - Goldman Sachs Chris Raymond - Piper Jaffray Operator Good morning. My name is Dan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Third Quarter 2018 Financial Results and Business Update. All lines have been placed on mute
Show less
Read more
Impact Snapshot
Event Time:
BIIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
News
- CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.MarketBeat
- Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006, an Innovative Antibody Drug Conjugate Targeting Folate Receptor a [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire
BIIB
Earnings
- 2/14/24 - Miss
BIIB
Sec Filings
- 2/26/24 - Form 4
- 2/22/24 - Form 144
- 2/21/24 - Form 4
- BIIB's page on the SEC website